Rolf M.F. Berger

Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.

Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.

Severe pregnancy-induced deterioration of truncal valve regurgitation in an adolescent patient with repaired truncus arteriosus.

Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?

Down syndrome and aberrant right subclavian artery.

Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification.

Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?

Biological serum markers in the management of pediatric pulmonary arterial hypertension.

Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.

Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis.

Pulse densitometer indocyanine green dilution curves: a simple applicable and accurate method for determination of cardiac shunts.

Pulmonary vascular remodeling in congenital heart disease: enhanced expression of heat shock proteins.

Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.

Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.

Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.

Clinical features of paediatric pulmonary hypertension: a registry study.

The origin of fetal sterols in second-trimester amniotic fluid: endogenous synthesis or maternal-fetal transport?

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.

Physiological interaction of heart and lung in thoracic irradiation.

Effect of balloon atrial septostomy on cerebral oxygenation in neonates with transposition of the great arteries.

The role of maternal-fetal cholesterol transport in early fetal life: current insights.

Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.

TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension.

The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.

Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency.

Frequency and prognostic significance of hemoptysis in pediatric pulmonary arterial hypertension.

A cornerstone of heart failure treatment is not effective in experimental right ventricular failure.

Effect of right ventricular outflow tract obstruction on right ventricular volumes and exercise capacity in patients with repaired tetralogy of fallot.

Pediatric pulmonary hypertension.

Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.

Ventricular remodelling after pulmonary valve replacement: comparison between pressure-loaded and volume-loaded right ventricles.

Pulmonary hypertension: smaller kids, smaller steps.

Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.

A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.

Identification of treatment goals in paediatric pulmonary arterial hypertension.

Current and advancing treatments for pulmonary arterial hypertension in childhood.

The challenges in paediatric pulmonary arterial hypertension.

Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction.

Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.

Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis.

What's the (end) point?

Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.

Right ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement?

Adverse pulmonary vascular remodeling in the Fontan circulation.

Pulmonary regurgitant volume is superior to fraction using background-corrected phase contrast MRI in determining the severity of regurgitation in repaired tetralogy of Fallot.

Ductus arteriosus aneurysm and vocal cord paralysis.

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.

Erythropoietin Attenuates Pulmonary Vascular Remodeling in Experimental Pulmonary Arterial Hypertension through Interplay between Endothelial Progenitor Cells and Heme Oxygenase.

Six-minute walking distance and decrease in oxygen saturation during the six-minute walk test in pediatric pulmonary arterial hypertension.

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion.

The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study.

Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.

Cardiovascular malformations caused by NOTCH1 mutations do not keep left: data on 428 probands with left-sided CHD and their families.

Common arterial trunk and ventricular non-compaction in Lrp2 knockout mice indicate a crucial role of LRP2 in cardiac development.

Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.

Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study.

Surgical options after Fontan failure.

A Hemodynamically Significant Patent Ductus Arteriosus Does Not Affect Cerebral or Renal Tissue Oxygenation in Preterm Infants.

Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.

Multisite Tissue Oxygenation Monitoring Indicates Organ-Specific Flow Distribution and Oxygen Delivery Related to Low Cardiac Output in Preterm Infants With Clinical Sepsis.

Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58].

Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.

Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.

Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension.

Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.

A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3.

Diminished liver microperfusion in Fontan patients: A biexponential DWI study.

Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.

Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension†.

Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.

Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension.

Diagnostic value of Doppler echocardiography for identifying hemodynamic significant pulmonary valve regurgitation in tetralogy of Fallot: comparison with cardiac MRI.

Pediatric pulmonary arterial hypertension: on the eve of growing up.

Fontan Circulation over Time.

Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study.

Cerebral and Renal Oxygen Saturation Are Not Compromised in the Presence of Retrograde Blood Flow in either the Ascending or Descending Aorta in Term or Near-Term Infants with Left-Sided Obstructive Lesions.

Volume load-induced right ventricular dysfunction in animal models: insights in a translational gap in congenital heart disease.

Amplitude-integrated electroencephalography during the first 72 h after birth in neonates diagnosed prenatally with congenital heart disease.

Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: A systematic review and meta-analysis.

Quality of life and sexual well-being in patients with a Fontan circulation: An explorative pilot study with a mixed method design.

Risk of cardiac tachyarrhythmia in patients with repaired tetralogy of Fallot: a multicenter cardiac MRI based study.

Pulmonary vasodilator therapy as treatment for patients with a Fontan circulation: the Emperor's new clothes?

Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease.

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.

Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail.

The Janus-faced Fontan circulation: unravelling its elusive pathophysiology.

Converging Paths of Pulmonary Arterial Hypertension and Cellular Senescence.

Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.

The Natural and Unnatural History of Congenital Aortic Arch Abnormalities Evaluated in an Adult Survival Cohort.

A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing.

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.

Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry.

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.

CMR feature tracking left ventricular strain-rate predicts ventricular tachyarrhythmia, but not deterioration of ventricular function in patients with repaired tetralogy of Fallot.

Thoracotomy Versus Sternotomy for Patent Ductus Arteriosus Closure in Preterm Neonates.

Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez.

The ever-expanding phenotypical spectrum of human TBX4 mutations: from toe to lung.

Failing Homeostasis of Quadriceps Muscle Energy- and pH Balance During Bicycling in a Young Patient With a Fontan Circulation.

Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension.

Reply to Ning : More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension.

Metabolic Remodeling in the Pressure-Loaded Right Ventricle: Shifts in Glucose and Fatty Acid Metabolism-A Systematic Review and Meta-Analysis.

Setting the stage for increasing diversity in congenital cardiology: let's celebrate the 75th anniversary of the Blalock-Thomas-Taussig shunt.

Serial cardiovascular magnetic resonance feature tracking indicates early worsening of cardiac function in Fontan patients.

Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants.

Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children.

TBX4 variants and pulmonary diseases: getting out of the 'Box'.

Onset of brain injury in infants with prenatally diagnosed congenital heart disease.

GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation.